Hypoparathyroidism: update of guidelines from the 2022 International Task Force
AUTOR(ES)
Clarke, Bart L.
FONTE
Archives of Endocrinology and Metabolism
DATA DE PUBLICAÇÃO
2022
RESUMO
ABSTRACT The 2022 International Task Force guidelines for chronic hypoparathyroidism will be published within several months in the Journal of Bone and Mineral Research. These guidelines update the original guidelines published in 2016, and include new information from literature published since then. Chronic postsurgical hypoparathyroidism is now defined as lasting for at least 12 months after surgery, rather than 6 months. Chronic postsurgical hypoparathyroidism may be predicted by serum PTH <10 pg/mL in the first 12-24 hours after surgery. The most common symptoms and complications of chronic hypoparathyroidism based on the literature are summarized in detail. How to monitor and manage patients with hypoparathyroidism is described in detail where recommendations can be given. These guidelines are intended to frame the diagnosis and care of patients with chronic hypoparathyroidism for at least the next five years.
Documentos Relacionados
- Diagnosis and treatment of hypoparathyroidism: a position statement from the Brazilian Society of Endocrinology and Metabolism
- Hypoparathyroidism: what is the best calcium carbonate supplementation intake form?
- Autosomal dominant hypoparathyroidism: a proband with concurrent nephrogenic diabetes insipidus.
- Neurological and psychiatric manifestations in idiopathic hypoparathyroidism: response to treatment.
- Celiac disease and hypoparathyroidism: cross-reaction of endomysial antibodies with parathyroid tissue.
